PROSPECTS OF COMBINING INTERLEUKIN-2 WITH IMMUNE CHECKPOINT INHIBITORS FOR CANCER THERAPY. (2020). Voprosy Onkologii, 66(1), 23-28. https://doi.org/10.37469/0507-3758-2020-66-1-23-28